Trial Profile
A Drug-drug Interaction Study Between the Novel Anti-hepatitis c Virus (HCV) Agent Daclatasvir and The Antidiabetic Agent Metformin in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Feb 2022
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Metformin
- Indications Hepatitis C
- Focus Pharmacokinetics
- Acronyms DATE-3
- 06 Apr 2016 Status changed from not yet recruiting to completed, according to ClinicalTrials.gov record.
- 08 Oct 2015 New trial record